LogiPharma 2021

20 - 22 April, 2021


LogiPharma Blog

At LogiPharma we love giving away plenty of free content, so you can always keep up with the latest developments in the industry. Below we have a few of our most popular articles and case studies.

Pharmaceutical Supply Chains Under Quarantine

It’s fair to say that the coronavirus outbreak has caught the world off guard. As governments and industry continue to feel the crisis out and come up with the best solutions to its challenges, many people are left with more questions than answers.

How MSD is Preparing for Brexit

Merck & Co starts ongoing research to stock and centre parts of its medical supply chain locally in London in anticipation of post Brexit setbacks in trade.

How Baxter is Winning Awards for Inclusivity

An equal opportunity leader in supply chain industry, Baxter fosters diversity in the workplace through inclusivity training to remove unconscious bias.

How Leo Pharma is Humanising the Supply Chain

Digitising the supply chain has improved efficiency, but people matter too! Leo Pharma had implemented a solution to bring back system usability.

How AbbVie is Collaborating on an Exciting Blockchain Pilot

Blockchain tech has been gaining traction as a possible solution for the perennial problems associated with healthcare: the under-utilisation and segregation of valuable data, trails for following patient records and other essential information, general data handling, compliance,and data security issues.

How Takeda Puts Diversity and Inclusion at the Heart of Its Strategy

Diverse and inclusive leadership provides greater opportunities for innovation and higher performance in financial returns. And as a leading business sector which touches the lives of everyone, the pharmaceutical and biotech industry should be seen as a globally dispersed but locally driven industry.

Pfizer is Using Mobile Technology to Boost Supply Chain Visibility

If pharma brands are unable to establish end-to-end visibility in their supply chains, it becomes very difficult, or even impossible, for them to accurately determine the origin, authenticity, and condition of any product passing through it.

How Eli Lilly is Using Wearables to Deliver Better Treatments

In 2017 Eli Lilly was looking for a way to develop a next-generation glucose monitoring system. The company decided on a device-driven strategy and partnered with Dexcom to help develop it. The goal of the project was to help Eli Lilly get closer to patients and, rather than being a simple provider of insulin medicine.

How Merck is Using Drones for Pharmaceutical Deliveries

Merck’s foray into the world of drone-facilitated delivery began in 2018 when Puerto Rico was hit by Hurricane Maria. Estimates vary, but it’s thought the disaster led to the deaths of nearly 3,000 people, and a year later, tens of thousands of Puerto Ricans are still living under temporary shelters of blue tarpaulin.

How Bayer is Putting Patient Centricity at the Heart of their Supply Chains

The future of healthcare is set to be replete with technology, from AI to smart health devices and mobile wellness management. As it opens its brand-new innovation hub in Manhattan, NYC, Johnson & Johnson is ready to bring medicine and technology together in ever-more innovative ways.

AstraZeneca Wants to See Pharma Discounts Passed onto Patients, Not Highly-Paid Middlemen

As rising drug prices continue to steal headlines, UK-based multinational pharmaceutical and biopharmaceutical company AstraZeneca has joined forces with a number of other pharma companies in freezing prices in the US for the remainder of 2018.

How Novartis is Preparing Their Supply Chains for Brexit

The UK’s impending withdrawal from the European Union is sending shockwaves through almost every industry, and the pharmaceutical business is no different. This has led to companies such as Novartis taking steps to lessen the impact.

Johnson & Johnson’s New Innovation Hub Is Advancing Health Tech

You might think keeping the patient at the center of consideration would be a no brainer for pharma companies, but in the swirling tumult of regulation, economics, logistics, and management, this noble ideal can sometimes fade into the background.

How Sanofi is Embracing Industry 4.0 and Blockchain Technology in its Supply Chain

The fourth industrial revolution, or Industry 4.0 as it’s known, refers to the fourth major paradigm shift which has occurred in production. The first revolution came with the introduction of water and steam powered machines, the second with electrically powered mass production and assembly lines, and the third saw computers and automation further streamline processes.